flakyteabag wrote:After previously discrediting the treatment,they are now calling for studies.
flakyteabag wrote:it absolutely boggles my mind that no studies have been done.
This drug also goes against all the standard theories about MS and you can imagine what would happen if LDN became the drug of choice
HarryZ wrote:flakyteabag wrote:it absolutely boggles my mind that no studies have been done.
It shouldn't.....and there is one reason only...nobody can make any money off of LDN at the current time. This drug also goes against all the standard theories about MS and you can imagine what would happen if LDN became the drug of choice.....a lot of people would be losing a lot of money!!!! Very sad but very true!!
True, but isn't there money to be made on trials? Does anyone know?Imagine if the trials drag on for years.
HarryZ wrote:Trials are terribly expensive propositions and the money has to come from someone....and that is a drug company who thinks there is a chance of getting a decent return on their investment. And so far, that's why we haven't seen any large LDN trials....and likely won't until somebody can find a big chunk of money.
HarryZ wrote:I don't think you have a great understanding of what is involved in clinical trials.
HarryZ wrote:The actual cost of the drug is the least of the expense worries. It's the entire structure of the trial that is the big cost. They must be carefully designed and approved, patients must be solicited, facilities and doctors obtained to conduct the trials, thousands of MRIs completed and analyzed and the data tabulated. And the trials are run over a minimum two year period and those are the Phase III trials after a drug has proven to be safe in Phase I and II trials. The costs run into the millions and then there is the additional cost for FDA approval which is required if you are going to advertise the fact that a particular drug has been approved for MS. And with the current patent situation with LDN, any other drug company could come along after all these millions have been spent by one company and this other company could manufacture the LDN and begin selling it without spending one cent on the research.....not a very attractive situation for any drug company!!!
Sure the insurance companies would be happy to eventually pay for LDN vs any of the CRABs but they won't be saving anything until LDN is properly approved for MS.
As for goodwill for anyone helping to pay for the trial costs....unfortunately that rarely if ever happens in today's world of medical drugs.
Users browsing this forum: Bethr